Literature DB >> 33307035

PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.

Maciej Szydłowski1, Sonia Dębek2, Monika Prochorec-Sobieszek3, Małgorzata Szołkowska4, Andrea M Tomirotti5, Przemysław Juszczyński2, Anna Szumera-Ciećkiewicz3.   

Abstract

Primary mediastinal large B-cell lymphoma (PMBL) cells depend on the constitutive activity of NF-κB and STAT transcription factors, which drive expression of multiple molecules essential for their survival. In a molecularly related B-cell malignant tumor (classic Hodgkin lymphoma), tumor Reed-Sternberg cells overexpress oncogenic (proviral integration site for Moloney murine leukemia virus (PIM) 1, 2, and 3 kinases in a NF-κB- and STAT-dependent manner and PIMs enhance survival and expression of immunomodulatory molecules. Given the multiple overlapping characteristics of Reed-Sternberg and PMBL cells, we hypothesized that PIM kinases may be overexpressed in PMBL and involved in PMBL pathogenesis. The expression of PIM kinases in PMBL diagnostic biopsy specimens was assessed and their role in survival and immune escape of the tumor cells was determined. PIMs were abundantly expressed in primary tumors and PMBL cell lines. Inhibition of PIM kinases was toxic to PMBL cells, attenuated protein translation, and down-regulated NF-κB- and STAT-dependent transcription of prosurvival factors BCL2A1, BCL2L1, and FCER2. Furthermore, PIM inhibition decreased expression of molecules engaged in shaping the immunosuppressive microenvironment, including programmed death ligand 1/2 and chemokine (C-C motif) ligand 17. Taken together, our data indicate that PIMs support PMBL cell survival and immune escape and identify PIMs as promising therapeutic targets for PMBL.
Copyright © 2021 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33307035     DOI: 10.1016/j.ajpath.2020.12.001

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  4 in total

Review 1.  Primary mediastinal large B cell lymphoma.

Authors:  Yating Yu; Xifeng Dong; Meifeng Tu; Huaquan Wang
Journal:  Thorac Cancer       Date:  2021-09-29       Impact factor: 3.500

2.  The Mutation of BTG2 Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma.

Authors:  Dan Guo; Lemin Hong; Hao Ji; Yuwen Jiang; Ling Lu; Xinfeng Wang; Hongming Huang
Journal:  J Inflamm Res       Date:  2022-03-10

3.  Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy.

Authors:  Xavier León; Jacinto García; Albert Pujol; Julia de Juan; Rosselin Vásquez; Miquel Quer; Mercedes Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-06       Impact factor: 3.236

4.  Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis.

Authors:  He Li; Lihui Xie; Lei Zhu; Zhaohuai Li; Rong Wang; Xiuxing Liu; Zhaohao Huang; Binyao Chen; Yuehan Gao; Lai Wei; Chang He; Rong Ju; Yizhi Liu; Xialin Liu; Yingfeng Zheng; Wenru Su
Journal:  Nat Commun       Date:  2022-10-04       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.